Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Inperia Advance Post-Market Retrospective Study
Sponsor: CID S.p.A.
Summary
The Inperia Advance Carbostent™ is a CE-marked infra-popliteal stent for treatment of infra-popliteal artery stenosis. The aim of this post-market retrospective study protocl P32203 is to collect clinical data of patients treated with Inperia Advance for the treatment of infra-popliteal artery stenosis in routine clinical practice. In order to obtain long-term follow-up data, the data collection will be limited to patients that have been treated with the device at least 12 months prior to the study start.
Official title: Inperia Advance Carbostent™ for Infra-popliteal Artery Stenosis. Evaluation of Safety and Performance in Everyday Clinical Practice: The Inperia Advance Post-Market Retrospective Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
32
Start Date
2023-03-09
Completion Date
2023-06-02
Last Updated
2026-10-22
Healthy Volunteers
No
Conditions
Interventions
Inperia Advance
Patients with infra-popliteal artery stenosis implanted with at least one Inperia Advance device
Locations (1)
CHRU Strasbourg
Strasbourg, France